Effects of various arterial infusion solutions on red blood cells in the newborn.
OBJECTIVE
To examine in vitro the effects of brief contact with various infusion solutions on red blood cells from newborn infants, as occurs in the "waste" syringe during routine blood sampling from umbilical artery catheters. The mixture of blood and solution in the "waste" syringe is usually reinfused into the baby. Reinfused red blood cells may be damaged by the infusion solution. It is hypothesised that an isotonic amino acid solution would cause no red blood cell agglutination and no more haemolysis than many commonly used solutions.


METHODS
Blood was obtained from the placentas of 15 normal term babies. Haemolysis was estimated by measuring plasma (free) haemoglobin after mock blood sampling. Agglutination was measured semiquantitatively by direct observation.


RESULTS
A 0.25% normal saline solution caused 5.4% haemolysis, significantly more than all the other fluids tested. There was less haemolysis with 0. 25% normal saline when there was complete mixing of blood and solution within the "waste" syringe. Normal saline and isotonic sodium acetate solutions caused < 0.1% haemolysis, significantly less than all the other fluids tested. The isotonic amino acid solution caused 0.8% haemolysis, which is similar to that caused by the remaining solutions tested. Agglutination was seen with isotonic dextrose and with the two isotonic amino acid solutions containing cysteine.


CONCLUSIONS
Isotonic amino acid solution (without added cysteine) caused no agglutination and the same or less haemolysis than many commonly used solutions and may offer advantages in nutrition and fluid balance.
Jackson
J K
JK
Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Derleth
D P
DP
D000372:Agglutination Tests; D000596:Amino Acids / Q000009:adverse effects; D003545:Cysteine / Q000009:adverse effects; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D005312:Fetal Blood; D005947:Glucose / Q000009:adverse effects; D006461:Hemolysis / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D007552:Isotonic Solutions; D010920:Placenta / Q000187:drug effects; D011247:Pregnancy; D019346:Sodium Acetate / Q000009:adverse effects; D012965:Sodium Chloride / Q000009:adverse effects
D000596:Amino Acids; D007552:Isotonic Solutions; D012965:Sodium Chloride; D019346:Sodium Acetate; D005947:Glucose; D003545:Cysteine